Yet, there are also indirect benefits. For instance, higher cotton yields provide more employment opportunities for agricultural laborers and a boost to rural transport and trading businesses. Income gains among farmers and farm workers entail higher demand for food and nonfood items, inducing growth and household income increases also in other local sectors. Using a village modeling approach and taking into account such spillovers to other markets and sectors, we find that each hectare of Bt cotton creates aggregate incomes that are $246 higher than those of conventional cotton ( Fig. 1) 9 . For the total Bt cotton area in India, this translates into an annual rural income gain of $1.87 billion. That is, each dollar of direct benefits is associated with over 80 cents of additional indirect benefits in the local economy.
In terms of income distribution, all types of households benefit, including those below the poverty line (Fig. 1) . Sixty percent of the gains accrue to the extremely and moderately poor. Bt cotton also generates net employment, with interesting gender implications. Compared to conventional cotton, Bt increases aggregate returns to labor by 42%, whereas the returns for hired female agricultural workers increase by 55% (ref. 9). This is largely due to additional labor employed for picking cotton, which is primarily a female activity in India. As is known, women's income has a particularly positive effect for child nutrition and welfare 10 .
Numerous studies show that sizeable direct benefits are also observed for other GM crop applications in developing countries (reviewed by M.Q. in ref. 4) , although a comprehensive evaluation of indirect social effects remains 4 . Claims that the technology is needed to ensure food security and poverty reduction are often considered empty promises and are dismissed as industry propaganda. This in turn prompts widespread public concerns about negative social implications in developing countries 5 . Correspondence in this journal has also documented how GM crop opposition in Europe is hurting farmers and researchers 6 . More seriously, through trade relations and lobbying efforts of antibiotech groups, European attitudes are spilling over to developing countries, where they crucially impede biotech developments as well 7 . Here, we summarize our recent research on the socioeconomic effects of insect-resistant Bacillus thuringiensis toxin (Bt) cotton in India 8, 9 . In this case, at least, there is strong evidence that the trait in this crop is already contributing to poverty reduction in the subcontinent. Bt cotton containing the gene for the Cry1Ac protein was commercialized in India in 2002. Although only a few Bt cotton hybrids were initially available, their number has increased substantially to over 150 since 2004. Some of them also carry the gene for Cry2Ab. In 2008, around five million Indian small-scale farmers had adopted Bt technology, with an average cotton area of 1.5 ha. Many of them live below the poverty line. Several rounds of a representative farm survey reveal that Bt-adopting farmers use 41% less pesticides and obtain 37% higher yields, resulting in an 89% gain in cotton profits on average 8 . In spite of seasonal and regional variation, these advantages have been sustainable over time. In monetary terms, mean profit gains are $135 per ha. For the 7.6 million ha currently under Bt cotton in India, this means an additional $1 billion in the hands of small-scale farmers. These are the technology's direct benefits.
choices are very limited, most likely because the big GM seed companies have purchased many of the independent producers 5 . Also, to get a decent price on required farm chemicals that are also sold by the GM seed companies, the farmers may have to purchase the GM seed even though the GM trait itself is useless to them. In addition, the purchase of GM seeds is sometimes a defensive measure because farmers know they can be put out of business by biotech companyinitiated lawsuits if their non-GM crops become contaminated by GM pollen from neighboring farms 6 . Finally, in developing countries the farmers frequently do not know what they are buying and they rely on local representatives who promote the latest, most expensive seeds that have not been properly tested for the area 7 . Third world officials have been known to take bribes from US companies 8 .
If Nature Biotechnology wants to represent itself as an unbiased advocate for technology, then it should ensure that its reporting covers all sides of an issue.
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Nature Biotechnology replies:
We agree with Schubert that the article's use of "public sector" as a descriptor for the crop scientists quoted in the piece was potentially misleading, given their ties to industry. Schubert also refers to the IAASTD report as support for the Gurian-Sherman manuscript. For this journal's analysis of IAASTD, the reader is referred to an editorial 1 and related correspondence 2,3 . volume 27 number 9 september 2009 nature biotechnology complete until 3 weeks of age 5 . Once these endfeet are in place, it may be that they trap much of the AAV9 entering the brain in the adult, thus preventing the widespread neuronal distribution seen in the neonates. The common belief among neuroscientists that the BBB is 'immature' in the neonate seems to stem from the view that because a system is developing it is necessarily immature and from acceptance of evidence produced by experiments in which very large volumes of test materials have been injected, thereby damaging fragile blood vessels in the developing brain [6] [7] [8] . Therefore, it is of concern that Foust et al. state in their Methods section that "virus injections were in a total volume of 100 µl of PBS." Given that newborn mice weigh 1-2 g, their total blood volume would be <100-200 µl. Intravenous injection of such a large proportion of the circulating blood volume would have a damaging effect even in adults, let alone on fragile blood vessels of the newborn 7 . In the context of normal physiological function, fragility does not equate with immaturity; rather, it describes a mechanical reaction when a physiological system is abused rather than being a manifestation of a developmental biological phenomenon. In the experiments of Foust et al., no controls were carried out to check on the integrity of the BBB. It would need to be clarified whether damage had occurred before the authors' explanation and our and Lowenstein's alternative explanation could be differentiated. The authors state that, in the adult, transduction was almost exclusively in astrocytes. There may be indirect effects on neurons via astrocytes with release, for example, of growth factors, but the proposal that AAV9 could facilitate gene therapy for adult diseases involving neurons, such as Parkinson's disease and Alzheimer's disease, seems premature on the basis of the evidence presented. a clear priority. The results reported here cannot be simply extrapolated, as impacts always depend on the conditions in a particular setting. Nonetheless, the fact that a firstgeneration GM crop like Bt cotton already contributes to poverty reduction and rural welfare growth has not been widely recognized up till now and might further the public debate. Intelligent policies need to ensure that future biotech developments will also be pro-poor.
